The predictive value of hemoglobin to creatinine ratio for contrast-induced nephropathy in percutaneous coronary

Sencer Çamci1, Mustafa Kinik1, Selma Ari1

  • 1Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.

Insights

The hemoglobin to creatinine ratio can predict contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI). A lower ratio indicates a higher risk of developing CIN after the procedure.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarkers

Background:

  • Contrast-induced nephropathy (CIN) is a significant risk following percutaneous coronary intervention (PCI).
  • Predictive markers for CIN are crucial for patient management and risk stratification.

Purpose of the Study:

  • To evaluate the predictive value of the hemoglobin to creatinine ratio for CIN development in patients undergoing PCI.
  • To identify key predictors of CIN in this patient population.

Main Methods:

  • Prospective evaluation of 500 patients undergoing PCI.
  • Calculation of baseline hemoglobin to creatinine ratio and glomerular filtration rate (GFR).
  • Definition of CIN based on serum creatinine increase 48-72 hours post-contrast.

Main Results:

  • CIN developed in 13.8% of patients.
  • Hemoglobin to creatinine ratio, ejection fraction (EF), and contrast amount were significant predictors of CIN.
  • Receiver operating characteristic (ROC) analysis showed good predictive performance for these markers (AUCs ranging from 0.694 to 0.731).

Conclusions:

  • The hemoglobin to creatinine ratio is an independent predictor of CIN in patients undergoing PCI.
  • EF and contrast amount also independently predict CIN development.
  • These findings highlight the utility of the hemoglobin to creatinine ratio as a simple predictive tool for CIN.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
149
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
239
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
330
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154